TY - JOUR T1 - Integrated Protein Network Analysis of Whole Exome Sequencing of Severe Preeclampsia JF - medRxiv DO - 10.1101/2020.11.23.20236885 SP - 2020.11.23.20236885 AU - Jessica Schuster AU - George A. Tollefson AU - Valeria Zarate AU - Anthony Agudelo AU - Joan Stabila AU - Ashok Ragavendran AU - James Padbury AU - Alper Uzun Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/07/22/2020.11.23.20236885.abstract N2 - Preeclampsia is a hypertensive disorder of pregnancy, which complicates up to 15 % of US deliveries. It is an idiopathic disorder with complex disease genetics associated with several different phenotypes. We sought to determine if the genetic architecture of preeclampsia can be described by clusters of patients with variants in genes in shared protein interaction networks. We performed a case-control study using whole exome sequencing on early onset preeclamptic mothers with severe features and control mothers with uncomplicated pregnancies. The study was conducted at Women & Infants Hospital of Rhode Island (WIH). A total of 143 patients were enrolled, 61 women with early onset preeclampsia with severe features based on ACOG criteria, and 82 control women at term, matched for race and ethnicity. The main outcomes are variants associated with severe preeclampsia and demonstration of the genetic architecture of preeclampsia. A network analysis and visualization tool, Proteinarium, was used to confirm there are clusters of patients with shared gene networks associated with severe preeclampsia. The majority of the sequenced patients appear in two significant clusters. We identified one case dominant and one control dominant cluster. Thirteen genes were unique to the case dominated cluster. Among these genes, LAMB2, PTK2, RAC1, QSOX1, FN1, and VCAM1 have known associations with the pathogenic mechanisms of preeclampsia. Using the exome-wide sequence variants, combined with these 13 identified network genes, we generated a polygenetic risk score for severe preeclampsia with an AUC of 0.57. Using bioinformatic analysis, we were able to identify subsets of patients with shared protein interaction networks, thus confirming our hypothesis about the genetic architecture of preeclampsia. The unique genes identified in the cluster associated with severe preeclampsia were able to increase the predictive power of the polygenic risk score.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by grants from the National Institutes of Health 5P20GM109035-05 and 5P20GM121298-05 and the Kilguss Research Core at Women & Infants Hospital.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study is a case/control study and this study was approved by the Institutional Review Board of Women and Infants Hospital (WIH) (Project ID: WIH 16-0031). Informed written consent was obtained from each mother (total of 143 mothers).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAfter acceptance of this manuscript by a peer-reviewed journal, data will be available to the public. ER -